BRIEF published on 02/13/2025 at 07:05, 1 year 9 months ago SCHOTT Pharma Begins Fiscal Year 2025 with Promising Results Revenue Growth EBITDA Margin Q1 Results High-value Solutions DCS Segment
BRIEF published on 02/13/2025 at 07:05, 1 year 9 months ago SCHOTT Pharma débute l'année fiscale 2025 avec des résultats prometteurs Marge EBITDA Croissance Des Revenus Résultats Du Premier Trimestre Des Solutions À Haute Valeur Ajoutée Segment DCS
PRESS RELEASE published on 02/13/2025 at 07:00, 1 year 9 months ago SCHOTT Pharma records good start into fiscal year and confirms full year outlook SCHOTT Pharma reports good start in Q1 2025 with EUR 230m revenues, confirms full year outlook. EBITDA margin at 25.1% as reported. High-value solutions share at 55% Revenues EBITDA Margin SCHOTT Pharma Full Year Outlook Q1 2025
BRIEF published on 02/04/2025 at 18:27, 1 year 9 months ago SCHOTT Pharma Holds Successful Annual General Meeting Annual General Meeting Shareholder Approval SCHOTT Pharma Profit Growth MDAX Promotion
BRIEF published on 02/04/2025 at 18:27, 1 year 9 months ago SCHOTT Pharma organise avec succès son assemblée générale annuelle SCHOTT Pharma Assemblée Générale Annuelle Approbation Des Actionnaires Croissance Des Bénéfices Promotion MDAX
PRESS RELEASE published on 02/04/2025 at 18:22, 1 year 9 months ago SCHOTT Pharma with successful Annual General Meeting: Shareholders approve all agenda items SCHOTT Pharma's successful Annual General Meeting for FY 2024 with all agenda items approved by shareholders, including new Supervisory Board member Dr. Wolfram Carius and KPMG as new auditor Annual General Meeting Shareholders SCHOTT Pharma KPMG Dr. Wolfram Carius
BRIEF published on 12/12/2024 at 07:05, 1 year 11 months ago SCHOTT Pharma Reports Strong Growth and Record Margins for FY 2024 Revenue Growth EBITDA Margin High-value Solutions Drug Delivery Systems Innovation And Expansion
BRIEF published on 12/12/2024 at 07:05, 1 year 11 months ago SCHOTT Pharma annonce une forte croissance et des marges record pour l'exercice 2024 Marge EBITDA Croissance Des Revenus Systèmes D'administration De Médicaments Des Solutions À Haute Valeur Ajoutée Innovation Et Expansion
PRESS RELEASE published on 12/12/2024 at 07:00, 1 year 11 months ago SCHOTT Pharma with strong growth and record margin after solid year-end finish SCHOTT Pharma AG & Co. KGaA reports strong growth and record margin for the fiscal year 2024, meeting 12% revenue growth target and achieving EBITDA margin of 27.8% Innovation Revenue EBITDA Margin SCHOTT Pharma Growth
BRIEF published on 12/04/2024 at 11:05, 1 year 11 months ago SCHOTT Pharma Introduces Efficient and Sustainable Cartridge Nest Design Sustainability GLP-1 Therapies Pharmaceutical Efficiency Cartridge Design Innovative Packaging
Published on 11/18/2026 at 00:35, 1 hour 10 minutes ago Route1 Appoints Tom Park to Board of Directors and Announces Board Changes
Published on 11/17/2026 at 23:40, 2 hours 5 minutes ago AI/ML Innovations Inc. Closes First Tranche of Private Placement
Published on 11/17/2026 at 23:00, 2 hours 45 minutes ago Alset AI Ventures Inc. Announces Extension of Annual General Meeting Deadline
Published on 11/17/2026 at 21:30, 4 hours 15 minutes ago Fairplay Ventures INC. Announces Filing of Filing Statement in Connection With Qualifying Transaction
Published on 11/17/2026 at 15:00, 10 hours 45 minutes ago Secure Blockchain's Agentic Solutions Signs Engineering Company, Expanding Enterprise AI Into Heavy Industry
Published on 11/18/2026 at 00:59, 46 minutes ago Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 11/17/2026 at 23:13, 2 hours 31 minutes ago EQS-Adhoc: M1 Kliniken AG plans move to the Prime Standard in 2027 and raises EBIT margin target for its Beauty segment to at least 25%
Published on 11/17/2026 at 22:00, 3 hours 45 minutes ago Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 11/17/2026 at 21:12, 4 hours 33 minutes ago EQS-Adhoc: JDC Group AG: Adjustment of Full-Year Guidance
Published on 11/17/2026 at 20:21, 5 hours 24 minutes ago Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 11/17/2026 at 18:00, 7 hours 45 minutes ago 20261117 - Accor - Accor to increase its stake in Ennismore
Published on 11/17/2026 at 18:00, 7 hours 45 minutes ago Accor - Accor se renforce au capital de Ennismore
Published on 11/17/2026 at 17:45, 8 hours ago EURAZEO COMPLETES THE SALE OF ITS STAKE IN AROMA-ZONE AND ITS REINVESTMENT ALONGSIDE PARTNERS GROUP
Published on 11/17/2026 at 17:45, 8 hours ago EURAZEO FINALISE LA CESSION DE SA PARTICIPATION DANS AROMA-ZONE ET SON REINVESTISSEMENT AUX COTES DE PARTNERS GROUP
Published on 11/17/2026 at 07:40, 18 hours 4 minutes ago SUEZ INTERNATIONAL SAS COMPLETES THE SALE OF C.10.65 MILLION SHARES OF ACEA S.P.A.